BioSpace News Archive

Biotech Beach

Locanabio Announces First Presentation of Data from its Next Generation Vectorized snRNA Exon-Skipping Platform Highlighting its Investigational LBIO-115 Program for the Treatment of Duchenne Muscular Dystrophy (DMD)

Locanabio, Inc. announced the first presentation of data from its next generation engineered small nuclear RNA, or snRNA, platform, which is designed to efficiently deliver targeted snRNA payloads via an adeno-associated virus for long-term therapeutic expression.

April 20, 2023

·

5 min read

Catalyst Pharmaceuticals Announces Third-Party Abstracts on FYCOMPA® (Perampanel) to be Presented at the Upcoming American Academy of Neurology 2023 Annual Meeting

Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq: CPRX) today announced that four abstracts highlighting FYCOMPA® (perampanel) CIII have been published and will be presented at the upcoming AAN 2023 Annual Meeting taking place in Boston, MA and virtually on April 22-27, 2023.

April 20, 2023

·

13 min read

Biotech Beach

RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy

Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced results from the RECOVER AF study.

April 20, 2023

·

5 min read

Business

Insmed to Host First Quarter 2023 Financial Results Conference Call on Thursday, May 4, 2023

Insmed Incorporated today announced that it will release its first quarter 2023 financial results on Thursday, May 4, 2023.

April 20, 2023

·

1 min read

BioMidwest

NICO Corporation’s ENRICH Trial Evaluating Minimally Invasive Parafascicular Surgery (MIPS) for Intracerebral Hemorrhage (ICH) to be Presented at the 2023 AANS Annual Scientific Meeting During Plenary Session I

NICO Corporation, a pioneer and leader in minimally invasive neurosurgery, today announced results from the completed ENRICH (Early MiNimally-invasive Removal of ICH) trial will be presented at the annual American Association of Neurological Surgeons (AANS) meeting in Los Angeles from April 21-24.

April 20, 2023

·

4 min read

Ventus Therapeutics Awarded Grant by The Michael J. Fox Foundation to Support Development of a NLRP3 PET Tracer

Ventus Therapeutics announced today that it has been awarded a $150,000 grant by The Michael J. Fox Foundation for Parkinson’s Research (MJFF).

April 20, 2023

·

4 min read

Business

Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies

Twist Bioscience Corporation today announced a collaboration with Astellas Pharma Inc.

April 20, 2023

·

6 min read

IRLAB Announces New Date for Publication of the Annual Report

IRLAB Therapeutics AB, a company that discovers and develops new treatments for Parkinson’s disease, announced that the company’s annual report for 2022 will be published during the week commencing April 24.

April 20, 2023

·

1 min read

Drug Development

OSE Immunotherapeutics Presents Additional Preclinical Updates on CLEC-1, a Novel Myeloid Immune Checkpoint in Immuno-Oncology

OSE Immunotherapeutics SA presented two additional posters reporting the latest research updates on CLEC-1, from its Myeloid platform, at the 2023 American Association for Cancer Research Annual Meeting held in Orlando on April 14-19.

April 20, 2023

·

8 min read

Drug Development

Promore Pharma Reports Outcome from Clinical Phase II Study with Ensereptide

Promore Pharma AB announces that the results from the company’s Phase II study PHSU05 with ensereptide in prevention of skin scarring have been concluded.

April 20, 2023

·

4 min read